Stockscreener 앱 받기
0.6735
1.37%
0.0091
시간 외 거래:
.67
-0.0035
-0.52%
전일 마감가:
$0.6644
열려 있는:
$0.65
하루 거래량:
520.95K
Relative Volume:
0.53
시가총액:
$39.55M
수익:
-
순이익/손실:
$-123.46M
주가수익비율:
-0.26
EPS:
-2.59
순현금흐름:
$-104.11M
1주 성능:
-8.45%
1개월 성능:
-2.93%
6개월 성능:
+20.70%
1년 성능:
-66.33%
1일 변동 폭
$0.6131
$0.6779
1주일 범위
$0.6131
$0.7579
52주 변동 폭
$0.2601
$2.525
바이오아틀라 Stock (BCAB) Company Profile
명칭
Bioatla Inc
전화
858-558-0708
주소
11085 TORREYANA ROAD, SAN DIEGO
BCAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.6735 | 39.01M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
바이오아틀라 Stock (BCAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-13 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | 개시 | JMP Securities | Mkt Outperform |
| 2022-05-05 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-06-28 | 개시 | ROTH Capital | Buy |
| 2021-05-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | BTIG Research | Buy |
| 2021-01-11 | 개시 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | JP Morgan | Overweight |
| 2021-01-11 | 개시 | Jefferies | Buy |
모두보기
바이오아틀라 주식(BCAB)의 최신 뉴스
Ready to Jump After Recent Trade: BioAtla Inc (BCAB) - setenews.com
Will BioAtla Inc. continue its uptrendRate Hike & Safe Entry Point Alerts - newser.com
Analyzing BioAtla Inc. with multi timeframe charts2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Sentiment analysis tools applied to BioAtla Inc.2025 Historical Comparison & Growth Focused Investment Plans - newser.com
Critical Financial Test Looms for Bioatla Shares - AD HOC NEWS
Published on: 2025-11-04 02:18:07 - newser.com
BioAtla Inc. stock outlook for YEAR2025 Historical Comparison & Smart Investment Allocation Tips - newser.com
Measuring BioAtla Inc.’s beta against major indices2025 Volatility Report & Community Shared Stock Ideas - newser.com
Is BioAtla Inc. a candidate for recovery playPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - newser.com
Why BioAtla Inc. stock is favored by top institutions2025 Technical Patterns & High Yield Stock Recommendations - newser.com
Analyzing BioAtla Inc. with risk reward ratio chartsJuly 2025 Pullbacks & Reliable Breakout Forecasts - newser.com
Regression analysis insights on BioAtla Inc. performanceEarnings Growth Report & Safe Capital Growth Tips - newser.com
What to do if you’re stuck in BioAtla Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com
BioAtla, Inc. (BCAB) stock forecast and price target - Yahoo! Finance UK
How supply chain issues affect BioAtla Inc. stockJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com
Chart overlay techniques for tracking BioAtla Inc.Quarterly Growth Report & Stock Timing and Entry Methods - newser.com
BioAtla, Inc. (BCAB) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What moving averages say about BioAtla Inc.Bond Market & Capital Efficiency Focused Ideas - newser.com
BioAtla’s Phase 1 Study on BA3182: A New Hope for Advanced Adenocarcinoma - MSN
BioAtla (BCAB) to Release Quarterly Earnings on Thursday - Defense World
바이오아틀라 (BCAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):